Betablockade contains metoprolol – selective β1 receptor blocker used in the treatment of a number of diseases of the cardiovascular system, especially hypertension.
Betablockade is used for the treatment of:
– angina pectoris;
– heart arrhythmia, particularly supraventricular tachycardia;
– prophylactic treatment to prevent cardiac death and re-infarction following the acute phase of a myocardial infarction;
– palpitations due to functional cardiac disorders;
– prophylaxis of migraine;
– stable symptomatic heart failure (NYHA II-IV, left ventricular ejection fraction < 40%), combined with other therapies for heart failure.
Subject to medical prescription.
Concentration and pharmaceutical form: 50 mg, 100 mg prolonged-release tablets